FDA Inspection 989069 — Pharmadax (Foshan) Co., Ltd.

Pharmadax (Foshan) Co., Ltd. — FEI 3008654992

The FDA completed an inspection of Pharmadax (Foshan) Co., Ltd. on September 23, 2016 in Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 23, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Foshan (China)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls